跳至主要内容
临床试验/NCT00879775
NCT00879775已完成2 期

Efficacy of Caffeine as an Adjuvant to Opioid Therapy in Cancer Pain: a Randomized, Double-blind, Placebo-controlled Trial

Korea Research Foundation2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2009年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
41
试验地点
2
主要终点
Numeric Rating of Scale (From 0 to 10) of Pain and Possible Side Effects (Drowsiness, Confusion, Nausea) of Opioids

研究概览

简要总结

Pain is a most common symptom and it has a high impact on quality of life in cancer patients. Many cancer patients have received opioid therapy, but also many of them have suffered from side effects of opioids. Drowsiness and confusion are common side effects of opioids. Caffeine is a well known psychostimulant,and it is widely used as an analgesics. Thus, the investigators aimed to prove the efficacy of intravenous caffeine administration as an adjuvant analgesics to opioids. At the same time, the investigators tried to find that the side effects of opioids could be ameliorated by caffeine.

详细描述

Previous studies on cancer pain lacked assessment of quality of life. And most of previous studies on cancer pain did not give attention to symptoms accompanied with pain. We include such variables as outcome measures, and aimed to evaluate the efficacy and the safety of intravenous caffeine in advanced cancer inpatients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Advanced (Stage IV) cancer inpatients
  • Adults aged over 18 years
  • Patients who have received opioid therapy and whose pain scales are under 6 (by numeric rating scale)
  • Patients who do not take caffeine beverage 48 hours before study period
  • Volunteers who provided written informed consent

排除标准

  • Sensitivity (palpitation,headache,irritability,insomnia) to caffeine
  • Uncontrolled hypertension and/or heart disease
  • Liver failure (alanine aminotransferase >= 100 IU/L)
  • Kidney failure (serum creatinine >= 2.0 mg/dL)
  • Patients taken theophylline
  • Gastroesophageal reflux disease
  • Chronic glaucoma
  • Cognitive impairment
  • Progressive pain over 7 (by numeric rating scale)

研究组 & 干预措施

Caffeine

Experimental

Intravenous injections of 200mg of caffeine with 100ml of normal saline over 1 hour

干预措施: Caffeine (Drug)

Placebo

Placebo Comparator

Intravenous injections of 100ml of normal saline over 1 hour

干预措施: Normal saline (Drug)

结局指标

主要结局

Numeric Rating of Scale (From 0 to 10) of Pain and Possible Side Effects (Drowsiness, Confusion, Nausea) of Opioids

时间窗: two days

Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; higher scores represent higher levels of pain, and possible side effects (drowsiness, confusion, nausea) of opioids.

Numeric Rating of Scale (From 0 to 10) of Possible Sleep Disturbance of Opioids

时间窗: two days

Scores were measured by Numeric Rating Scale. Scores range from 0 to 10; a higher score represents a higher level of sleep disturbance.

次要结局

  • Degree of Fatigue at the Point of Time With Numeric Rating Scale From 0 to 10(two days)
  • Health-related Quality of Life(two days)
  • Impact of Symptom Burden to Daily Life (by MD Anderson Symptom Inventory-Korean)(two days)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验